secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biomea Fusion, Inc. (BMEA)
CIK:        0001840439
Form:       8-K
Filed at:   2026-09-22T20:01:33+00:00
Accession:  0001193125-26-397870
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomea Fusion moves BMF-650 Phase I topline readout to October 2026
-------------------------------------------------------------------

- Company now expects topline results for BMF-650 Phase I (GLP-131) in October 2026.
- Trial enrolls obese, otherwise healthy volunteers; no results disclosed yet.
- Timing update issued September 22, 2026; prior expectation unspecified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840439/000119312526397870/0001193125-26-397870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840439/000119312526397870/bmea-20260922.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-397870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer